%0 Journal Article %1 noauthororeditor %A Almzaiel, Munther Hasshem Barorr | Anwar Jasib %D 2023 %J CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCE %K Bowel Crohn's D, HCgp39 Inflammatory Ulcerative Vitamin colitis, disease), disease, %N 5 %P 123-134 %T Chitinase 3-Like-1 CPa9-HNE and Vit-D levels in Crohn's Disease %U https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/1794/1885 %V 4 %X Background: Inflammatory Bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal tract, leading to various symptoms and complications, which includes conditions like Crohn's disease (CD)and ulcerative colitis (UC). These conditions are characterized by periods of active inflammation and remission, leading to a range of symptoms such as abdominal pain, diarrhea, weight loss, and fatigue. A defect in immune response, a product of environmental and genetic factors, are considered central cause to pathogenesis and etiology of IBD1 GP39 is a cartilage-specific protein associated with immune responses, predominantly expressed by activated T cells. Its involvement in the pathogenesis of IBD has been demonstrated through studies showing elevated levels of GP39 in the serum of IBD patients compared to healthy controls. Recently established that IBD associated with Vit-D deficiency. Objectives: The study aimed to address the potential advantages of (HCgp39 and Vit-D ) as biomarkers for IBD and its medical treatment. Methods: The total number of samples collected was 120 samples from all subjects, where 60 samples were collected from patients (D=30 and UC=30)) The study also included collecting 60 samples from healthy subjects as a control group. A (5 mL) blood sample was obtained from every patient as part of the study's protocol. Serum was separated from by centrifugation for HCgp39 and Vitamin D3 analysis by ELISA. Results: The results show a decrease in Vit-D3 was indicated in CD and UC patient groups (P ≤ 0.05), while HCgp38 levels were non-changed significantly in patient groups compared to control subjects, (P > 0.05). Conclusions: In conclusion, the results suggests that serum decreased Vit- D correlated well with disease activity in both CD and UC. Targeting Vit-D3 could present a novel approach to regulate metabolic pathways and modulate immune responses, potentially providing new avenues for drug development and personalized treatment strategies for individuals with IBD

@article{noauthororeditor, abstract = {Background: Inflammatory Bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal tract, leading to various symptoms and complications, which includes conditions like Crohn's disease (CD)and ulcerative colitis (UC). These conditions are characterized by periods of active inflammation and remission, leading to a range of symptoms such as abdominal pain, diarrhea, weight loss, and fatigue. A defect in immune response, a product of environmental and genetic factors, are considered central cause to pathogenesis and etiology of IBD[1] GP39 is a cartilage-specific protein associated with immune responses, predominantly expressed by activated T cells. Its involvement in the pathogenesis of IBD has been demonstrated through studies showing elevated levels of GP39 in the serum of IBD patients compared to healthy controls. Recently established that IBD associated with Vit-D deficiency. Objectives: The study aimed to address the potential advantages of (HCgp39 and Vit-D ) as biomarkers for IBD and its medical treatment. Methods: The total number of samples collected was 120 samples from all subjects, where 60 samples were collected from patients (D=30 and UC=30)) The study also included collecting 60 samples from healthy subjects as a control group. A (5 mL) blood sample was obtained from every patient as part of the study's protocol. Serum was separated from by centrifugation for HCgp39 and Vitamin D3 analysis by ELISA. Results: The results show a decrease in Vit-D3 was indicated in CD and UC patient groups (P ≤ 0.05), while HCgp38 levels were non-changed significantly in patient groups compared to control subjects, (P > 0.05). Conclusions: In conclusion, the results suggests that serum decreased Vit- D correlated well with disease activity in both CD and UC. Targeting Vit-D3 could present a novel approach to regulate metabolic pathways and modulate immune responses, potentially providing new avenues for drug development and personalized treatment strategies for individuals with IBD}, added-at = {2024-01-11T10:01:50.000+0100}, author = {Almzaiel, Munther Hasshem Barorr | Anwar Jasib}, biburl = {https://www.bibsonomy.org/bibtex/22b805b1b14b42adf44a29255d0cb55aa/centralasian_20}, interhash = {8ea4c4d4d2f42490ad7e06cef56c4c38}, intrahash = {2b805b1b14b42adf44a29255d0cb55aa}, issn = {2660-4159}, journal = {CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCE}, keywords = {Bowel Crohn's D, HCgp39 Inflammatory Ulcerative Vitamin colitis, disease), disease,}, language = {english}, month = sep, number = 5, pages = {123-134}, timestamp = {2024-01-11T10:01:50.000+0100}, title = {Chitinase 3-Like-1 [CPa9-HNE] and Vit-D levels in Crohn's Disease}, url = {https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/1794/1885}, volume = 4, year = 2023 }